• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Flumequine Sodium

Flumequine Sodium

Product ID F4881
Cas No. 42835-68-7
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $56.40 In stock
5 g $180.00 In stock
25 g $561.40 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Flumequine is a fluoroquinolone antibiotic commonly used in veterinary medicine. Flumequine exhibits antibacterial efficacy through the inhibition of bacterial DNA gyrase. This compound also displays other activity, inhibiting GABA-A receptors in the ileum, and displays cancer-related activity in the liver, although reports conflict as to whether flumequine is chemopreventive or carcinogenic. Additionally, this compound was previously explored as a treatment for urinary tract infection in humans, although is not currently used in that manner.

Product Info

Cas No.

42835-68-7

Purity

≥98%

Formula

C14H11FNNaO3

Formula Wt.

283.23

Appearance

White to off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

F4881 MSDS PDF

Info Sheet

F4881 Info Sheet PDF

References

Kuroiwa Y, Umemura T, Nishikawa A, et al. Lack of in vivo mutagenicity and oxidative DNA damage by flumequine in the livers of gpt delta mice. Arch Toxicol. 2007 Jan;81(1):63-9. PMID: 16802149.

Vik-Mo FT, Bergh O, Samuelsen OB. Efficacy of orally administered flumequine in the treatment of vibriosis caused by Listonella anguillarum in atlantic cod Gadus morhua. Dis Aquat Organ. 2005 Nov 9;67(1-2):87-92. PMID: 16385813.

Koutsoviti-Papadopoulou M, Kounenis G, Elezoglou V. Inhibitory effect of flumequine, enoxacin and norfloxacin on the GABA-induced contractile effect on the guinea pig ileum. Gen Pharmacol. 1995 Oct;26(6):1391-5. PMID: 7590136.

Schena FP, Gesualdo L, Caracciolo G. A multicentre study of flumequine in the treatment of urinary tract infections. J Antimicrob Chemother. 1988 Jan;21(1):101-6. PMID: 3356617.

Smith JT. The mode of action of 4-quinolones and possible mechanisms of resistance. J Antimicrob Chemother. 1986 Nov;18 Suppl D:21-9. PMID: 3542946.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G8800

    GW-788388

    ALK5 (activin-like) antagonist.  
    ≥97%
  • S3449

    Simvastatin

    Statin; HMG-CoA reductase inhibitor, potential ...

    ≥98%
  • N1982

    Neuromedin U, rat

    Endogenous neuropeptide, involved in energy hom...

    ≥95%
  • A0971

    Adrenocorticotropic Hormone (4-10), human

    Endogenous peptide hormone fragment, involved i...

    ≥95%
  • B1668

    Berteroin

    Thio sulforaphane analog, ITC.

    ≥97%
  • C002041

    Cabazitaxel

    Taxoid that disrupts the microtubular network i...

    ≥98%
  • D5746

    Dolasetron

    5-HT3 antagonist.

    ≥98%
  • C0376

    Catharanthine base

    Alkaloid found in Catharanthus, precursor in sy...

    ≥98%
  • T0116

    2″,3″-Dihydrocephalomannine

    Cephalomannine derivative found in Taxus; poten...

    ≥96%
  • R2512

    RGD

    Tripeptide, binds cell surface integrins.

    ≥95%
  • B8261

    Bupivacaine

    BK/SK, Kv1, Kv3, TASK-2 K+ channel blocker, vol...

    ≥99%
  • K1676

    Ketoconazole

    Imidazole; 14-α demethylase inhibitor.

    ≥98%
  • C000082

    C-82

    beta-catenin inhibitor

    ≥99%
  • I7360

    Isosorbide Mononitrate

    NO donor.

    ≥98%
  • I538583

    Inosine

    Adenosine analog

    ≥98%
  • L0362

    Lapatinib free base

    Inhibitor of EGFR/HER2 (ErbB2).

    ≥99%
  • B1973

    Besifloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • N1986

    Neuropeptide Y, human/rat

    Endogenous peptide neurotransmitter, involved i...

    ≥95%
  • R3476

    RITA

    p53 activator.

    ≥98%
  • M5756

    Montelukast Sodium

    CysLT1 antagonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only